Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Cash Flows From Operating Activities | |||||
Net Income | 2,783,000 | 5,309,000 | 5,257,000 | 3,626,000 | 1,711,000 |
Depreciation Amortization | 445,000 | 1,501,000 | 1,132,000 | 753,000 | 374,000 |
Income taxes - deferred | N/A | 1,242,000 | N/A | N/A | N/A |
Accounts receivable | -681,000 | -391,000 | -163,000 | -167,000 | -34,000 |
Accounts payable and accrued liabilities | 191,000 | 425,000 | 444,000 | -530,000 | -266,000 |
Other Working Capital | -727,000 | 93,000 | 67,000 | -690,000 | -237,000 |
Other Operating Activity | 634,000 | 1,781,000 | 639,000 | 1,113,000 | 554,000 |
Operating Cash Flow | $2,645,000 | $9,960,000 | $7,376,000 | $4,105,000 | $2,102,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -119,000 | -529,000 | -347,000 | -221,000 | -95,000 |
Net Acquisitions | -372,000 | -308,000 | -180,000 | -100,000 | -63,000 |
Purchase Of Investment | -267,000 | -2,230,000 | -1,838,000 | -1,391,000 | -970,000 |
Sale Of Investment | 311,000 | 2,793,000 | 1,890,000 | 1,346,000 | 444,000 |
Investing Cash Flow | $-447,000 | $-274,000 | $-475,000 | $-366,000 | $-684,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -33,000 | 23,000 | 423,000 | 23,000 | 23,000 |
Debt Repayment | -7,000 | -25,000 | -18,000 | -13,000 | -6,000 |
Common Stock Issued | 62,000 | 254,000 | 214,000 | 149,000 | 85,000 |
Common Stock Repurchased | -1,431,000 | -1,410,000 | -905,000 | -900,000 | -895,000 |
Dividend Paid | -1,137,000 | -4,107,000 | -3,077,000 | -2,051,000 | -1,027,000 |
Other Financing Activity | 37,000 | -247,000 | -221,000 | 18,000 | 26,000 |
Financing Cash Flow | $-2,509,000 | $-5,512,000 | $-3,584,000 | $-2,774,000 | $-1,794,000 |
Exchange Rate Effect | 15,000 | 29,000 | 29,000 | 23,000 | 16,000 |
Beginning Cash Position | 9,303,000 | 5,100,000 | 5,100,000 | 5,100,000 | 5,100,000 |
End Cash Position | 9,007,000 | 9,303,000 | 8,446,000 | 6,088,000 | 4,740,000 |
Net Cash Flow | $-296,000 | $4,203,000 | $3,346,000 | $988,000 | $-360,000 |
Free Cash Flow | |||||
Operating Cash Flow | 2,645,000 | 9,960,000 | 7,376,000 | 4,105,000 | 2,102,000 |
Capital Expenditure | -119,000 | -529,000 | -347,000 | -221,000 | -95,000 |
Free Cash Flow | 2,526,000 | 9,431,000 | 7,029,000 | 3,884,000 | 2,007,000 |